SCHEMBL22803232

SCHEMBL22803232

CCN(CC)CCNC(=O)c1c(C)[nH]c(C(C)(C)C)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
KDR P35968 13/20 0.47
PRKAA1 Q13131 10/20 0.47
PRKAA2 P54646 8/20 0.47
PDGFRB P09619 7/20 0.47
FGFR1 P11362 5/20 0.47
EGFR P00533 6/20 0.45
CSF1R P07333 3/20 0.45
FLT3 P36888 3/20 0.45
KIT P10721 3/20 0.45
PLK4 O00444 2/20 0.45
DCLK1 O15075 2/20 0.45
PDPK1 O15530 2/20 0.45
DAPK3 O43293 2/20 0.45
ROCK2 O75116 2/20 0.45
RPS6KA5 O75582 2/20 0.45
RPS6KA4 O75676 2/20 0.45
MAP4K4 O95819 2/20 0.45
CHEK2 O96017 2/20 0.45
NTRK1 P04629 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19442393 0.84 ALDH1A1 (0.55) ALDH1A1KDRPRKAA1PRKAA2PDGFRB
SCHEMBL24336951 0.81 ALDH1A1 (0.52) ALDH1A1KDRPRKAA1PRKAA2PDGFRB
SCHEMBL15132782 0.80 ALDH1A1 (0.67) ALDH1A1KDRPRKAA1PRKAA2PDGFRB
SCHEMBL1044420 0.80 KDR (0.59) ALDH1A1KDRPRKAA1PRKAA2PDGFRB
SCHEMBL2730804 0.79 ALDH1A1 (0.54) ALDH1A1KDRPRKAA1PRKAA2PDGFRB
SCHEMBL21916086 0.78 ALDH1A1 (0.50) ALDH1A1KDRPRKAA1PRKAA2PDGFRB
SCHEMBL12118142 0.78 KDR (0.50) ALDH1A1KDRPRKAA1PRKAA2PDGFRB
SCHEMBL24336612 0.77 ALDH1A1 (0.49) ALDH1A1KDRPRKAA1PRKAA2PDGFRB
SCHEMBL15132781 0.75 KDR (0.55) KDRPRKAA1PRKAA2PDGFRBFGFR1
SCHEMBL12281600 0.74 ALDH1A1 (0.46) ALDH1A1KDRPRKAA1PRKAA2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12037342-B2 Substituted eneoxindoles and uses thereof GILEAD SCIENCES, INC. (US) 2024-07-16 US disclosed
US-20230183262-A1 SUBSTITUTED ENEOXINDOLES AND USES THEREOF GILEAD SCIENCES, INC. 2023-06-15 US disclosed
US-20200392153-A1 SUBSTITUTED ENEOXINDOLES AND USES THEREOF GILEAD SCIENCES, INC. 2020-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183262-A1 SUBSTITUTED ENEOXINDOLES AND USES THEREOF HIPK1, HPGDS, HIPK3 ALDH1A1 1940/4885KDR 3759/4885PRKAA1 342/4885
US-12037342-B2 Substituted eneoxindoles and uses thereof HIPK1, HPGDS, HIPK3 ALDH1A1 1940/4885KDR 3759/4885PRKAA1 342/4885
US-20200392153-A1 SUBSTITUTED ENEOXINDOLES AND USES THEREOF HIPK1, HPGDS, HIPK3 ALDH1A1 1940/4885KDR 3759/4885PRKAA1 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.